As a result of Mindray¡¯s consistent efforts in developing new CLIA products, we are excited to announce that we are launching two new inflammation assays ¨C IL-6 and sCD14-ST globally on 1st December 2022. To better meet the needs of our customers, we have incorporated IL-6, PCT, and sCD14-ST into the inflammation solution for clinical application and management. To ensure it is easy to work with for clinical laboratories, the panel is designed to be usable on all Mindray CLIA platforms.

Now we are pleased to invite you to an academic webinar on the upcoming IL-6 and sCD14-ST that will take place on 1st December 2022. We look forward to meeting you at the online event.